This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Related articles in BJP
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by HOLMES, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HOLMES, C.
The British Journal of Psychiatry (2002) 180: 131-134
© 2002 The Royal College of Psychiatrists

OLD AGE PSYCHIATRY PAPERS

Genotype and phenotype in Alzheimer's disease{dagger}

CLIVE HOLMES, MRCPsych

Thornhill Research Unit, University of Southampton, Moorgreen Hospital, Botley Road, West End, Southampton SO30 3JB, UK

Declaration of interest None.

{dagger} See editorial, pp. 97–98, this issue.

ABSTRACT

Background Patients with Alzheimer's disease show a wide variation in clinical phenotype. Genetic research has been largely concerned with the role of mutations or common variants as risk factors for the disease. Do genetic factors also influence clinical phenotype?

Aims To examine the evidence that genetic factors influence the clinical expression of the disease in addition to influencing risk.

Method A selective review was made of the key literature.

Results Mutations in three genes, coding for amyloid precursor protein, presenilin-1 and presenilin-2, and a common variation ({epsilon}4) in another gene, APOE, have been shown to lead to an earlier development of the disease. More recently, genetic association and twin studies have suggested a role for genetic factors in the development of other aspects of clinical phenotype, notably the appearance of non-cognitive symptoms.

Conclusions In Alzheimer's disease genetic variation influences a number of aspects of clinical phenotype.


Related articles in BJP:

Highlights of this issue
ELIZABETH WALSH
BJP 2002 180: 0. [Full Text]  

Old age psychiatry
ALISTAIR BURNS and IAN G. McKEITH
BJP 2002 180: 97-98. [Full Text]  



This article has been cited by other articles:


Home page
 J. Neurol. Neurosurg. PsychiatryHome page
K. L Brickell, J. B Leverenz, E. J Steinbart, M. Rumbaugh, G. D Schellenberg, D. Nochlin, T. H Lampe, I. E Holm, V. V. Deerlin, W. Yuan, et al.
Clinicopathological concordance and discordance in three monozygotic twin pairs with familial Alzheimer's disease
J. Neurol. Neurosurg. Psychiatry, October 1, 2007; 78(10): 1050 - 1055.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
K. L. Brickell, E. J. Steinbart, M. Rumbaugh, H. Payami, G. D. Schellenberg, V. Van Deerlin, W. Yuan, and T. D. Bird
Early-onset Alzheimer disease in families with late-onset Alzheimer disease: a potential important subtype of familial Alzheimer disease.
Arch Neurol, September 1, 2006; 63(9): 1307 - 1311.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
C Holmes, C Ballard, D Lehmann, A D. Smith, H Beaumont, I N Day, M N. Khan, S Lovestone, M McCulley, C M Morris, et al.
Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variation
J. Neurol. Neurosurg. Psychiatry, May 1, 2005; 76(5): 640 - 643.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
P. H. Reddy, S. McWeeney, B. S. Park, M. Manczak, R. V. Gutala, D. Partovi, Y. Jung, V. Yau, R. Searles, M. Mori, et al.
Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease
Hum. Mol. Genet., June 15, 2004; 13(12): 1225 - 1240.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. R. Farmery, L. O. Tjernberg, S. E. Pursglove, A. Bergman, B. Winblad, and J. Naslund
Partial Purification and Characterization of {gamma}-Secretase from Post-mortem Human Brain
J. Biol. Chem., June 27, 2003; 278(27): 24277 - 24284.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. PsychiatryHome page
S. Shamas-Ud-Din and C. Holmes
Genetics of Down's syndrome and Alzheimer's disease * Authors' reply
The British Journal of Psychiatry, August 1, 2002; 181(2): 167 - 168.
[Full Text]

Home page
 Br. J. PsychiatryHome page
A. BURNS and I. G. McKEITH
Old age psychiatry
The British Journal of Psychiatry, February 1, 2002; 180(2): 97 - 98.
[Full Text] [PDF]